Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109
Characteristics of study population at index date
Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109
Type of statin used
Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109
Outcomes where short-term effects may be apparent-all time
periods after the index date and first 12 months shown separately
Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109
Outcomes with more longer term onset:
first 12 months after index date excluded
Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109
All cancers stratified by duration of follow-up
Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109
Major vascular outcomes and all cause mortality
Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109